{"id":118042,"date":"2021-07-12T13:46:21","date_gmt":"2021-07-12T13:46:21","guid":{"rendered":"https:\/\/fin2me.com\/?p=118042"},"modified":"2021-07-12T13:46:21","modified_gmt":"2021-07-12T13:46:21","slug":"novo-nordisk-to-buy-prothenas-heart-drug-in-deal-worth-up-to-1-2-billion","status":"publish","type":"post","link":"https:\/\/fin2me.com\/business\/novo-nordisk-to-buy-prothenas-heart-drug-in-deal-worth-up-to-1-2-billion\/","title":{"rendered":"Novo Nordisk to buy Prothena's heart drug in deal worth up to $1.2 billion"},"content":{"rendered":"
FILE PHOTO: Flags are seen outside Novo Nordisk headquarters in Copenhagen, Denmark, February 5, 2020. REUTERS\/Jacob Gronholt-Pedersen\/File Photo<\/figcaption>

(Reuters) – Danish drugmaker Novo Nordisk will acquire U.S. drug developer Prothena Corp\u2019s experimental heart therapy, PRX004, in a deal that could be worth up to $1.23 billion, the companies said on Monday.<\/p>\n

The acquisition is in line with Novo\u2019s strategy to diversify its core insulin portfolio that has been facing tough competition, prompting it to turn toward newer diabetes and obesity drugs to revive growth.<\/p>\n

Under the agreement, Prothena will receive $100 million in upfront and near-term clinical milestone payments for PRX004, currently in a mid-stage trial.<\/p>\n

Prothena in December had reported positive data from an early-stage trial of PRX004 to treat hereditary ATTR amyloidosis, a life-threatening genetic disease that affects the heart, nerves and other organs.<\/p>\n

Novo Nordisk said it would focus on developing PRX004 for ATTR cardiomyopathy, a potentially fatal form of the disease characterized by a build-up of amyloid deposits in cardiac tissue.<\/p>\n

The Danish firm in June last year had agreed to buy AstraZeneca spin-off Corvidia Therapeutics for an initial $725 million to expand into cardiovascular disease treatments.<\/p>\n

Prothena\u2019s pipeline includes drugs being developed to treat several neurodegenerative diseases including Alzheimer\u2019s disease and Parkinson\u2019s as well as disorders like AL amyloidosis.<\/p>\n

Source: Read Full Article<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

FILE PHOTO: Flags are seen outside Novo Nordisk headquarters in Copenhagen, Denmark, February 5, 2020. REUTERS\/Jacob Gronholt-Pedersen\/File Photo(Reuters) – Danish drugmaker Novo Nordisk will acquire […]<\/p>\n","protected":false},"author":3,"featured_media":118041,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[],"yoast_head":"\nNovo Nordisk to buy Prothena's heart drug in deal worth up to $1.2 billion - Fin2me<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/fin2me.com\/business\/novo-nordisk-to-buy-prothenas-heart-drug-in-deal-worth-up-to-1-2-billion\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Novo Nordisk to buy Prothena's heart drug in deal worth up to $1.2 billion - Fin2me\" \/>\n<meta property=\"og:description\" content=\"FILE PHOTO: Flags are seen outside Novo Nordisk headquarters in Copenhagen, Denmark, February 5, 2020. REUTERS\/Jacob Gronholt-Pedersen\/File Photo(Reuters) – Danish drugmaker Novo Nordisk will acquire [...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/fin2me.com\/business\/novo-nordisk-to-buy-prothenas-heart-drug-in-deal-worth-up-to-1-2-billion\/\" \/>\n<meta property=\"og:site_name\" content=\"Fin2me\" \/>\n<meta property=\"article:published_time\" content=\"2021-07-12T13:46:21+00:00\" \/>\n<meta name=\"author\" content=\"Mark\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/fin2me.com\/wp-content\/uploads\/2021\/07\/Novo-Nordisk-to-buy-Prothenas-heart-drug-in-deal-worth-up-to-1.2-billion.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Mark\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/fin2me.com\/business\/novo-nordisk-to-buy-prothenas-heart-drug-in-deal-worth-up-to-1-2-billion\/\",\"url\":\"https:\/\/fin2me.com\/business\/novo-nordisk-to-buy-prothenas-heart-drug-in-deal-worth-up-to-1-2-billion\/\",\"name\":\"Novo Nordisk to buy Prothena's heart drug in deal worth up to $1.2 billion - Fin2me\",\"isPartOf\":{\"@id\":\"https:\/\/fin2me.com\/#website\"},\"datePublished\":\"2021-07-12T13:46:21+00:00\",\"dateModified\":\"2021-07-12T13:46:21+00:00\",\"author\":{\"@id\":\"https:\/\/fin2me.com\/#\/schema\/person\/ad0e9920e03d3b41c7ad02a18375d76a\"},\"breadcrumb\":{\"@id\":\"https:\/\/fin2me.com\/business\/novo-nordisk-to-buy-prothenas-heart-drug-in-deal-worth-up-to-1-2-billion\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/fin2me.com\/business\/novo-nordisk-to-buy-prothenas-heart-drug-in-deal-worth-up-to-1-2-billion\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/fin2me.com\/business\/novo-nordisk-to-buy-prothenas-heart-drug-in-deal-worth-up-to-1-2-billion\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/fin2me.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Business\",\"item\":\"https:\/\/fin2me.com\/category\/business\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Novo Nordisk to buy Prothena's heart drug in deal worth up to $1.2 billion\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/fin2me.com\/#website\",\"url\":\"https:\/\/fin2me.com\/\",\"name\":\"Fin2me\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/fin2me.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/fin2me.com\/#\/schema\/person\/ad0e9920e03d3b41c7ad02a18375d76a\",\"name\":\"Mark\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/fin2me.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/39b72719fb75a2d3c7d7695026648602?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/39b72719fb75a2d3c7d7695026648602?s=96&d=mm&r=g\",\"caption\":\"Mark\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Novo Nordisk to buy Prothena's heart drug in deal worth up to $1.2 billion - Fin2me","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/fin2me.com\/business\/novo-nordisk-to-buy-prothenas-heart-drug-in-deal-worth-up-to-1-2-billion\/","og_locale":"en_US","og_type":"article","og_title":"Novo Nordisk to buy Prothena's heart drug in deal worth up to $1.2 billion - Fin2me","og_description":"FILE PHOTO: Flags are seen outside Novo Nordisk headquarters in Copenhagen, Denmark, February 5, 2020. REUTERS\/Jacob Gronholt-Pedersen\/File Photo(Reuters) – Danish drugmaker Novo Nordisk will acquire [...]","og_url":"https:\/\/fin2me.com\/business\/novo-nordisk-to-buy-prothenas-heart-drug-in-deal-worth-up-to-1-2-billion\/","og_site_name":"Fin2me","article_published_time":"2021-07-12T13:46:21+00:00","author":"Mark","twitter_card":"summary_large_image","twitter_image":"https:\/\/fin2me.com\/wp-content\/uploads\/2021\/07\/Novo-Nordisk-to-buy-Prothenas-heart-drug-in-deal-worth-up-to-1.2-billion.jpg","twitter_misc":{"Written by":"Mark","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/fin2me.com\/business\/novo-nordisk-to-buy-prothenas-heart-drug-in-deal-worth-up-to-1-2-billion\/","url":"https:\/\/fin2me.com\/business\/novo-nordisk-to-buy-prothenas-heart-drug-in-deal-worth-up-to-1-2-billion\/","name":"Novo Nordisk to buy Prothena's heart drug in deal worth up to $1.2 billion - Fin2me","isPartOf":{"@id":"https:\/\/fin2me.com\/#website"},"datePublished":"2021-07-12T13:46:21+00:00","dateModified":"2021-07-12T13:46:21+00:00","author":{"@id":"https:\/\/fin2me.com\/#\/schema\/person\/ad0e9920e03d3b41c7ad02a18375d76a"},"breadcrumb":{"@id":"https:\/\/fin2me.com\/business\/novo-nordisk-to-buy-prothenas-heart-drug-in-deal-worth-up-to-1-2-billion\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/fin2me.com\/business\/novo-nordisk-to-buy-prothenas-heart-drug-in-deal-worth-up-to-1-2-billion\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/fin2me.com\/business\/novo-nordisk-to-buy-prothenas-heart-drug-in-deal-worth-up-to-1-2-billion\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/fin2me.com\/"},{"@type":"ListItem","position":2,"name":"Business","item":"https:\/\/fin2me.com\/category\/business\/"},{"@type":"ListItem","position":3,"name":"Novo Nordisk to buy Prothena's heart drug in deal worth up to $1.2 billion"}]},{"@type":"WebSite","@id":"https:\/\/fin2me.com\/#website","url":"https:\/\/fin2me.com\/","name":"Fin2me","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/fin2me.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/fin2me.com\/#\/schema\/person\/ad0e9920e03d3b41c7ad02a18375d76a","name":"Mark","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/fin2me.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/39b72719fb75a2d3c7d7695026648602?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/39b72719fb75a2d3c7d7695026648602?s=96&d=mm&r=g","caption":"Mark"}}]}},"_links":{"self":[{"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/posts\/118042"}],"collection":[{"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/comments?post=118042"}],"version-history":[{"count":0,"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/posts\/118042\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/media\/118041"}],"wp:attachment":[{"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/media?parent=118042"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/categories?post=118042"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/tags?post=118042"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}